Okami Medical, Inc., an innovative leader in the medical device sector, is excited to announce a successful funding round, securing $32.5 million in investments. This funding is a significant milestone for the company, whose mission centers around transforming peripheral vascular intervention through cutting-edge technology and pioneering solutions that tackle critical unmet clinical needs. With this new capital, Okami Medical aims to accelerate the development and commercialization of its groundbreaking medical devices designed to enhance patient outcomes and streamline healthcare delivery in vascular procedures. The company is focused on not only advancing its product pipeline but also on fostering partnerships with healthcare professionals to ensure that their innovations align with real-world clinical requirements. “This investment enables us to push the boundaries of what is possible in the peripheral vascular landscape, ultimately leading to improved care for patients,” said the CEO of Okami Medical. The funding will support the necessary clinical trials and regulatory processes aimed at bringing these vital solutions to market more rapidly. As the demand for effective and reliable medical devices continues to rise, Okami Medical is poised to make a meaningful impact, demonstrating how targeted funding can drive innovation and create opportunities for better healthcare delivery. The team at Okami Medical is eager to embark on this next chapter and is more committed than ever to its vision of pioneering advanced technologies that meet urgent medical needs.







